Acetylsalicylic acid Completed Phase 4 Trials for Transient Ischaemic Attack (TIA) / Ischemia, Brain / Arteriosclerosis Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00161070ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial